Literature DB >> 20868553

Esophageal cancer: diagnosis and management.

Steven H Lin1, Joe Y Chang.   

Abstract

Esophageal cancer is the 7th leading cause of cancer deaths worldwide. While squamous cell carcinoma is the most prevalent histology internationally, adenocarcinoma of the distal esophagus accounts for nearly 50% of cases in developed countries due to the differences in the etiologic factors such as gastroesophageal reflux disease (GERD) and obesity that predominate. While surgery is the mainstay of treatment of this disease, the utilization of chemoradiation, either used postoperatively or neoadjuvantly, has become a standard practice in the United States. What is the optimal management approach is still an area of contention, however, and may be different in different regions around the world. This article reviews some of these controversies, including the role for surgery in patients treated with definitive chemoradiation. At the end, we will also outline recommendations regarding radiotherapy procedures and techniques.

Entities:  

Mesh:

Year:  2010        PMID: 20868553     DOI: 10.5732/cjc.010.10151

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  9 in total

1.  Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.

Authors:  Li Yin; Hao Wu; Jian Gong; Jian-Hao Geng; Fan Jiang; An-Hui Shi; Rong Yu; Yong-Heng Li; Shu-Kui Han; Bo Xu; Guang-Ying Zhu
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

2.  CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis.

Authors:  Shu-Mei Yan; Lili Liu; Wan-Yi Gu; Li-Yun Huang; Yi Yang; Yu-Hua Huang; Rong-Zhen Luo
Journal:  J Oncol       Date:  2021-05-18       Impact factor: 4.375

3.  Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy.

Authors:  Zhi-guo Zhou; Chan-jun Zhen; Wen-wen Bai; Ping Zhang; Xue-ying Qiao; Jun-li Liang; Xian-shu Gao; Shuo-shuo Wang
Journal:  Radiat Oncol       Date:  2015-02-27       Impact factor: 3.481

4.  Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.

Authors:  Xiao-Feng Xie; Qing Yang; Jun Chi; Xian-Zi Yang; Hui-Yun Wang; Guo-Liang Xu
Journal:  Chin J Cancer       Date:  2017-01-19

5.  Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.

Authors:  Haoli Wang; Jianwen Zhou; Qiong He; Yu Dong; Yanhui Liu
Journal:  Mol Med Rep       Date:  2017-05-03       Impact factor: 2.952

6.  Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.

Authors:  Xinran Wang; Bing Hu; Jinhu Chen; Feihong Xie; Dan Han; Qian Zhao; Hongfu Sun; Chengrui Fu; Chengxin Liu; Zhongtang Wang; Haiqun Lin; Wei Huang
Journal:  BMC Cancer       Date:  2022-02-24       Impact factor: 4.430

7.  Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.

Authors:  Junjie Wang; Weilin Yang; Tao Wang; Xiaoyong Chen; Jiancheng Wang; Xiaoran Zhang; Chuang Cai; Beilong Zhong; Jiabin Wu; Zhenguang Chen; Andy Peng Xiang; Weijun Huang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

8.  Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis.

Authors:  Kaikai Zhao; Youjiao Si; Liangchao Sun; Xiangjiao Meng; Jinming Yu
Journal:  Radiat Oncol       Date:  2020-10-21       Impact factor: 3.481

9.  Clinical Significance of Plasma Levels of Gluconeogenic Amino Acids in Esophageal Cancer Patients.

Authors:  Mahsa Taherizadeh; Masoud Khoshnia; Sedigheh Shams; Zahra Hesari; Hamidreza Joshaghani
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.